FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy

Abstract Our aim was to analyse whether biomarkers extracted from baseline 18F-FDG PET before anti-PD1 treatment contribute to prognostic survival information for early risk stratification in metastatic melanoma. Fifty-six patients, without prior systemic treatment, BRAF wild type, explored using 18...

Full description

Bibliographic Details
Main Authors: A. Flaus, V. Habouzit, N. De Leiris, J. P. Vuillez, M. T. Leccia, J. L. Perrot, N. Prevot, F. Cachin
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-98310-3

Similar Items

Similar Items